← Back to Clinical Trials
RecruitingNCT04934540
The Global En Bloc Resection of Bladder Tumour Registry
◆ AI Clinical Summary
Plain-language summary for patients
Trial Parameters
ConditionBladder Cancer
SponsorChinese University of Hong Kong
Study TypeOBSERVATIONAL
PhaseN/A
Enrollment2,000
SexALL
Min Age18 Years
Max AgeN/A
Start Date2020-01-01
Completion2026-12-31
Interventions
En bloc resection of bladder tumour
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The study aims to collect data on ERBT globally in order to clarify its role in the management of bladder cancer over a 5-year observation period.
Eligibility Criteria
Inclusion Criteria: * Adult patients \>=18 years old with informed consent * Presence of bladder tumour undergoing transurethral ERBT Exclusion Criteria: * Presence or previous history of upper tract urothelial carcinoma * Presence of other active malignancy * Pregnancy
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology